FLGT Fulgent Genetics, Inc.

10.780.10 (+0.89%)
IEX price: 3:59:00 PM

Quote

Previous Close
-
Day Range
-
52 Week Range
$3.05-$16.50
Volume
693,553
Avg Volume
294,630
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$201.60M
Enterprise Value (EV)
$168.79M
PE Ratio
-
EV/EBITDA
-58.06
Price/Sales
9.36
Price/Book
3.95
PEG Ratio
-

Financials

Revenue
$21.35M
Gross Profit
$10.65M
EBITDA
-$2.91M
EPS, ttm
-$0.12
Profit Margin
-
Revenue/Employee
$173.59K
Next Earnings Date
3/4/2020 (107 days)
Debt to Equity
-
Debt
-
Cash
$31.03M
Net Debt
-

Performance

Beta
0.79
200 Day Moving Avg
$7.81
50 Day Moving Avg
$11.23
52 Week Change
220.72%
YTD Change
207.79%
1 Month Change
-5.24%
3 Month Change
4.71%
6 Month Change
91.74%
1 Year Change
215.98%
2 Year Change
223.64%
5 Year Change
16.34%

Share Count

Shares Outstanding
18.7M
Float
6.4M
Restricted Shares
12.3M
Restricted Shares, %
65.85%

Fulgent Genetics, Inc. Company Details

Sector: Health Services

Industry: Medical/Nursing Services

CEO: Ming Hsieh

Website: http://www.fulgentgenetics.com

Description: Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Employees: 123